Abbott Laboratories ABT
SEC filings (XBRL) · quarterly · fiscal year ends December 31
Pick a second metric to compare.
Source: SEC EDGAR 10-Q/10-K XBRL, CIK 1800; every value is traced to its filing on EDGAR. Retrieved Oct 11, 2026. Quarters labelled by fiscal quarter with the calendar period end. Q4 = annual minus Q1–Q3; cash-flow quarters derived from year-to-date figures.
Last 84 quarters
| Q2 2024Jun 30, 2024 | Q3 2024Sep 30, 2024 | Q4 2024Dec 31, 2024 | Q1 2025Mar 31, 2025 | Q2 2025Jun 30, 2025 | Q3 2025Sep 30, 2025 | Q4 2025Dec 31, 2025 | Q1 2026Mar 31, 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.4B | $10.6B | $11.0B | $10.4B | $11.1B | $11.4B | $11.5B | $11.2B |
| Operating income | $1.7B | $1.9B | $1.9B | $1.7B | $2.1B | $2.1B | $2.3B | $1.3B |
| Net income | $1.3B | $1.6B | $9.2B | $1.3B | $1.8B | $1.6B | $1.8B | $1.1B |
| Capital spending | $0.5B | $0.6B | $0.7B | $0.5B | $0.5B | $0.5B | $0.7B | $0.4B |
| Operating cash flow | $2.0B | $2.7B | $2.9B | $1.4B | $2.0B | $2.8B | $3.3B | $1.3B |
| Free cash flow | $1.4B | $2.1B | $2.1B | $0.9B | $1.5B | $2.3B | $2.6B | $0.9B |
| Capex / operating cash flow | 27.2% | 20.6% | 25.1% | 34.2% | 24.5% | 17.8% | 20.8% | 30.3% |
| Shares outstanding | 1.740B | 1.734B | 1.734B | 1.740B | 1.740B | 1.739B | 1.738B | 1.742B |
| Share count change, y/y | +0.3% | −0.1% | −0.1% | +0.0% | +0.0% | +0.3% | +0.2% | +0.1% |
| Diluted shares (weighted avg.) | 1.751B | 1.748B | — No figure for Q4 2024: Fiscal Q4: the 10-K gives only the 12-month weighted average; a quarterly weighted average cannot be derived by subtraction. | 1.747B | 1.751B | 1.749B | — No figure for Q4 2025: Fiscal Q4: the 10-K gives only the 12-month weighted average; a quarterly weighted average cannot be derived by subtraction. | 1.747B |
— Diluted shares (weighted avg.): No figure for Q4 2024: Fiscal Q4: the 10-K gives only the 12-month weighted average; a quarterly weighted average cannot be derived by subtraction.
— Diluted shares (weighted avg.): No figure for Q4 2025: Fiscal Q4: the 10-K gives only the 12-month weighted average; a quarterly weighted average cannot be derived by subtraction.
Diluted shares (weighted avg.): fiscal Q4 is blank because the 10-K gives 12-month figures only.
XBRL tags used
| Revenue | SalesRevenueNet | Jun 2009 to Dec 2016 |
|---|---|---|
RevenueFromContractWithCustomerExcludingAssessedTax | Mar 2017 to Mar 2026 | |
| Operating income | OperatingIncomeLoss | Jun 2009 to Mar 2026 |
| Net income | ProfitLoss | Jun 2009 to Dec 2011 |
NetIncomeLoss | Mar 2012 to Mar 2026 | |
| Capital spending | PaymentsToAcquirePropertyPlantAndEquipment | Jun 2009 to Mar 2026 |
| Operating cash flow | NetCashProvidedByUsedInOperatingActivities | Jun 2009 to Sep 2010 |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Dec 2010 to Dec 2010 | |
NetCashProvidedByUsedInOperatingActivities | Mar 2011 to Jun 2011 | |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Sep 2011 to Dec 2011 | |
NetCashProvidedByUsedInOperatingActivities | Mar 2012 to Mar 2026 | |
| Free cash flow | ocf - capex: NetCashProvidedByUsedInOperatingActivities, PaymentsToAcquirePropertyPlantAndEquipment | Jun 2009 to Sep 2010 |
ocf - capex: NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, PaymentsToAcquirePropertyPlantAndEquipment | Dec 2010 to Dec 2010 | |
ocf - capex: NetCashProvidedByUsedInOperatingActivities, PaymentsToAcquirePropertyPlantAndEquipment | Mar 2011 to Jun 2011 | |
ocf - capex: NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, PaymentsToAcquirePropertyPlantAndEquipment | Sep 2011 to Dec 2011 | |
ocf - capex: NetCashProvidedByUsedInOperatingActivities, PaymentsToAcquirePropertyPlantAndEquipment | Mar 2012 to Mar 2026 | |
| Capex / operating cash flow | capex / ocf * 100: PaymentsToAcquirePropertyPlantAndEquipment, NetCashProvidedByUsedInOperatingActivities | Jun 2009 to Sep 2010 |
capex / ocf * 100: PaymentsToAcquirePropertyPlantAndEquipment, NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Dec 2010 to Dec 2010 | |
capex / ocf * 100: PaymentsToAcquirePropertyPlantAndEquipment, NetCashProvidedByUsedInOperatingActivities | Mar 2011 to Jun 2011 | |
capex / ocf * 100: PaymentsToAcquirePropertyPlantAndEquipment, NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Sep 2011 to Dec 2011 | |
capex / ocf * 100: PaymentsToAcquirePropertyPlantAndEquipment, NetCashProvidedByUsedInOperatingActivities | Mar 2012 to Mar 2026 | |
| Shares outstanding | dei:EntityCommonStockSharesOutstanding | Jun 2009 to Mar 2026 |
| Diluted shares (weighted avg.) | WeightedAverageNumberOfDilutedSharesOutstanding | Jun 2009 to Mar 2026 |
Where a company changed tags, each quarter uses the tag it was reported under; the newest tag is primary.